ArticleCancer management and research2019

Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer.

Jinghao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.